Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Camerlo

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|October 1, 1995
Minor breakpoint cluster region (m-BCR) positive chronic myeloid leukaemia with an acute lymphoblastic leukaemia onset: a case reportR T Costello, J Gabert, V Brunel, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patientsN Vey, D Blaise, M Lafage, et al.
Bone Marrow Transplantation|August 1, 1997
High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancerP Viens, G Gravis, D Genre, et al.
Bone Marrow Transplantation|June 1, 2002
Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantationA C Braud, M P Mathoulin Portier, V J Bardou, et al.
Bone Marrow Transplantation|August 26, 1998
Clinical and economic comparison of lenograstim-primed blood cells (BC) and bone marrow (BM) allogeneic transplantationC Faucher, C Fortanier, P Viens, et al.
Bone Marrow Transplantation|September 1, 1996
A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignanciesN Vey, B De Prijck, C Faucher, et al.
Anticancer Research|August 6, 2000
Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: a phase I-II studyD Genre, P Viens, G Gravis, et al.
Bone Marrow Transplantation|June 25, 2002
Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimensD Genre, P Viens, F Bertucci, et al.
European Cytokine Network|June 5, 1998
Benefits of granulocyte-colony-stimulating factor after stem cell transfusion in intensive sequential chemotherapy for breast cancerP Viens, D Genre, C Protière, et al.
Leukemia & Lymphoma|August 28, 1998
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institutionS Oddou, N Vey, P Viens, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|October 1, 1995
Minor breakpoint cluster region (m-BCR) positive chronic myeloid leukaemia with an acute lymphoblastic leukaemia onset: a case reportR T Costello, J Gabert, V Brunel, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patientsN Vey, D Blaise, M Lafage, et al.
Bone Marrow Transplantation|August 1, 1997
High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancerP Viens, G Gravis, D Genre, et al.
Bone Marrow Transplantation|June 1, 2002
Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantationA C Braud, M P Mathoulin Portier, V J Bardou, et al.
Bone Marrow Transplantation|August 26, 1998
Clinical and economic comparison of lenograstim-primed blood cells (BC) and bone marrow (BM) allogeneic transplantationC Faucher, C Fortanier, P Viens, et al.
Bone Marrow Transplantation|September 1, 1996
A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignanciesN Vey, B De Prijck, C Faucher, et al.
Anticancer Research|August 6, 2000
Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: a phase I-II studyD Genre, P Viens, G Gravis, et al.
Bone Marrow Transplantation|June 25, 2002
Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimensD Genre, P Viens, F Bertucci, et al.
European Cytokine Network|June 5, 1998
Benefits of granulocyte-colony-stimulating factor after stem cell transfusion in intensive sequential chemotherapy for breast cancerP Viens, D Genre, C Protière, et al.
Leukemia & Lymphoma|August 28, 1998
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institutionS Oddou, N Vey, P Viens, et al.
Pageof 5